Hospitalizations are at their lowest levels for almost a year in Norway, prompting the nation’s top medical expert to declare the Chinese Communist Party (CCP) virus is over.

“The pandemic is so to say over,” Norwegian Institute of Public Health infection control chief physician Preben Aavitsland said according to Humans Are Free.

Aavitsland is so confident there will be no further CCP virus outbreaks he suggests life will gradually return to pre-pandemic conditions in the Nordic country.

“We can start to prepare ourselves for corona (CCP virus) taking very little space in our everyday lives,” he said.

The remarks came after the institute discovered the deadly disease resulted in much fewer hospital admissions and deaths across Norway. There were only five deaths in July, and only 14 patients are hospitalized across the country, according to the GreatGameIndia.

The chief physician released a bar chart confirming Norway reported the lowest number of hospitalized patients since the end of last summer.

“That was the pandemic,” he said according to Google Translate.

“In May, June and July, we had a total of 23,877 proven cases, of which 25 died,” Aavitsland added according to Humans Are Free.

The health professional estimates the May and July 2021 infection fatality rate (IFR), or proportion of people who died from the CCP Virus infection, was between 0.05 and 0.2. During a typical flu season the IFR is about 0.1 according to University of Oslo demographic researcher Svenn-Erik Mamelund.

Even if the Delta strain spreads, the number of hospitalizations and fatalities will not approach levels seen last summer, according to Aavitsland. He claimed the virus “will not disappear” and only pose a “minor threat.”

It will take several years for the world to have the pandemic under control. The clinician vowed to share knowledge and skills with other nations that are still experiencing the pandemic.

“It is not [completely] over until it is over for everyone,” he said.

Norwegian health authorities announced in May that vaccines produced by Johnson & Johnson and AstraZeneca would only be administered to those who want them due to adverse reactions reported in multiple European countries.

The decision came despite the institute recommending that neither dose be administered routinely due to the risk of developing serious blood clots and other “serious side effects.”

Norway found four out of eight patients who developed clots died on March 11. Denmark raised similar concerns, and stopped administering AstraZeneca vaccines altogether.

Although clots were mainly detected from the AstraZeneca vaccine, authorities recommended against administering Johnson & Johnson because it used the same formula.

Norwegian Institute of Public Health director Camilla Stoltenberg revealed side effects from the AstraZeneca injection are clearly associated with the Johnson & Johnson jab.

“It is clear that the rare but serious side effects that we have seen with AstraZeneca also appear with the use of Janssen,” she said according to the Daily Mail. “There is great uncertainty as to the prevalence, and whether it occurs more often in some groups–such as according to age and gender.”

One young person in 60,000 cases is estimated to be at risk of developing blood clots from the same vaccines in the United Kingdom. The ratio drops to one person in 20,000 in Norway.